About the Journal

Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI) is an open access journal seeking to bridge the full scope of explorations between basic research on drug discovery and clinical studies for all forms of dementia and Alzheimer's Disease. TRCI accelerates the conversion of abstract facts into practical knowledge of dementia and Alzheimer's Disease: specifically, to translate what is learned at the bench into bedside applications. TRCI is also interested in Clinical Trials. Review our Author Guidelines and submit your manuscript to TRCI.

DADM is now indexed in the Emerging Sources Citation Index (ESCI).

Reasons to Publish with Us:

• Sound editorial guidance for your queries and flexibility around submission requirements.
• Rigorous review from an internationally recognized editorial team, and a CiteScore over 6.
• Open Access format makes your research free to read and share, with author copyright retention.
• Bridges knowledge gaps in the field and publishes the annual AD drug development pipeline.

Your Open Access fees may be covered...check now.